Sonia Bruña

Dr. Sonia Bruña

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2015 in Organometallics
Verified
Journal Article
Closed access
DNDaniel Nieto
Daniel Nieto
SBSonia Bruña
Sonia Bruña
AGAna Ma González-Vadillo
Ana Ma González-Vadillo
JPJosefina Perles
Josefina Perles
FHFERNANDO CARRILLO HERMOSILLA
FERNANDO CARRILLO HERMOSILLA
ICIsabel Cuadrado
Isabel Cuadrado

25 October 2011 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
DNDaniel Nieto
Daniel Nieto
AGAna M. González-Vadillo
Ana M. González-Vadillo
SBSonia Bruña
Sonia Bruña
CPCésar J. Pastor
César J. Pastor
CRCarla Ríos-Luci
Carla Ríos-Luci
ICIsabel Cuadrado
Isabel Cuadrado
A new family of heterometallic compounds 3–6 containing ferrocenyl and platinum(II) centers has been synthesized by reaction of 1-β-aminoethylferrocene (1) and 1,1′-bis(β-aminoethyl)ferrocene (2) with Pt(II) precursors. Using K2[PtCl4] as the Pt(II) source, the cis-square-planar neutral compounds [Fe{η5-C5H4(CH2)2NH2}2PtCl2] (3) and [{Fe(η5-C5H4(CH2)2NH2)(η5-C5H5)}2PtCl2] (5) were obtained. Reaction of cis-[PtCl2(dmso)2] with 1 and 2 resulted in the displacement of dmso and chloride ligands from the platinum coordination sphere, affording the cationic and neutral compounds [Fe{η5-C5H4(CH2)2NH2}2Pt(dmso)Cl]Cl (4) and [Fe(η5-C5H4(CH2)2NH2)(η5-C5H5)Pt(dmso)Cl2] (6). Compounds 3–6 were thoroughly characterized using multinuclear (1H, 13C, 195Pt) NMR, IR spectroscopy, ESI mass spectrometry and elemental analysis. Single-crystal X-ray analysis of heterometallic 6 confirmed the cis geometry of the molecule and revealed that the platinum atom is held in a perfect square-planar geometry. The electrochemical behaviour of the heterometallic compounds 3–6, which has been examined by cyclic (CV) and square wave (SWV) voltammetries in dichloromethane and dmso solution, is characterized by the reversible one-electron oxidation of the ferrocene moieties. The results of the biological activity studies revealed that the organometallic complex 5 is active against all cell lines with GI50 values in the range 1.7–2.3 μM. When compared to the standard anticancer drug cisplatin, heterotrimetallic 5, possessing two aminoethylferrocenyl units coordinated to the Pt(II) center, showed a greater activity profile in the colon cancer cell line. Cell cycle studies revealed that the new mixed compound exhibits a mechanism of action different to cisplatin.

29 September 2011 in Macromolecules
Verified
Journal Article
Closed access
MZMagdalena Zamora
Magdalena Zamora
SBSonia Bruña
Sonia Bruña
BGBeatriz Alonso Garrido
Beatriz Alonso Garrido
ICIsabel Cuadrado
Isabel Cuadrado

5 February 2014 in Macromolecules
Verified
Journal Article
Closed access
IMIgnacio Martínez-Montero
Ignacio Martínez-Montero
SBSonia Bruña
Sonia Bruña
AGAna Ma González-Vadillo
Ana Ma González-Vadillo
ICIsabel Cuadrado
Isabel Cuadrado

2 June 2010 in Organometallics
Verified
Journal Article
Closed access
SBSonia Bruña
Sonia Bruña
AGAna Ma González-Vadillo
Ana Ma González-Vadillo
DNDaniel Nieto
Daniel Nieto
CPCésar Pastor
César Pastor
ICIsabel Cuadrado
Isabel Cuadrado

3 January 2012 in Macromolecules
Verified
Journal Article
Closed access
SBSonia Bruña
Sonia Bruña
AGAna Ma González-Vadillo
Ana Ma González-Vadillo
DNDaniel Nieto
Daniel Nieto
CPCésar J. Pastor
César J. Pastor
ICIsabel Cuadrado
Isabel Cuadrado